Alembic Pharmaceuticals has informed that a Meeting of Board of Directors of the Company shall be held on 16th May, 2018, to consider and approve Audited Financial Results of the Company for the financial year ended 31st March, 2018; to consider and recommend dividend on Equity Shares, if any, for the financial year ended 31st March, 2018. The trading window shall remain closed from 13th May, 2018 to 18th May, 2018 for the above referred purpose.
The above information is a part of company’s filings submitted to BSE.
